期刊
MODERN RHEUMATOLOGY
卷 19, 期 4, 页码 443-446出版社
TAYLOR & FRANCIS LTD
DOI: 10.1007/s10165-009-0181-1
关键词
Leflunomide; Polymyositis; Rheumatoid arthritis
类别
Although rheumatoid arthritis (RA) and myositis are major autoimmune diseases, co-occurrence of the two is rare. We treated a patient who developed polymyositis (PM) following the treatment of RA with leflunomide. Prednisolone (PSL) in combination with methotrexate (MTX) was effective in managing the PM, but the RA relapsed during the treatment. Based on the clinical course, we suspect that the PM was induced by the leflunomide treatment and suggest that clinicians should consider the possibility of this rare adverse event in cases of cholestyramine-resistant elevation of transaminases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据